Clinical trial
Maximizing Native Arteriovenous Fistulae Rates. Is Routine Colour Doppler Vascular Mapping in Pre-operative Planning of Value? A Retrospective Study.
NCT02705417 is registered in ClinicalTrials.gov with Medifil AE as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Maximizing Native Arteriovenous Fistulae Rates. Is Routine Colour Doppler Vascular Mapping in Pre-operative Planning of Value? A Retrospective Study.
- Lead sponsor
- Medifil AE
- Phase
- Observational
- Overall status
- Completed
- Start date
- January 31, 2012
- Completion date
- January 31, 2015
- Enrollment
- 136 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
arteriovenous shunt, hemodialysis, kidney failure